Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 27.53 CNY -2.13% Market Closed
Market Cap: 6.4B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Sirio Pharma Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sirio Pharma Co Ltd
Cost of Revenue Peer Comparison

Comparables:
1044
603605
300957
300146
G
2367

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cost of Revenue
-ÂĄ2.5B
CAGR 3-Years
-21%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cost of Revenue
-ÂĄ15.2B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Proya Cosmetics Co Ltd
SSE:603605
Cost of Revenue
-ÂĄ3.2B
CAGR 3-Years
-28%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Cost of Revenue
-ÂĄ1.5B
CAGR 3-Years
-31%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cost of Revenue
-ÂĄ2.9B
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cost of Revenue
-ÂĄ577m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sirio Pharma Co Ltd's Cost of Revenue?
Cost of Revenue
-2.5B CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Cost of Revenue amounts to -2.5B CNY.

What is Sirio Pharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Sirio Pharma Co Ltd have been -21% over the past three years , -19% over the past five years .

Back to Top